Application of double filtration plasmapheresis(DFPP) in reducing the risks of metabolic syndrome

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CRIS

Registry ID

KCT0000356

Enrollment

Registered

2012-02-09

Start date

2011-08-23

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : double filtration plasma pheresis implemented each 2 times

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The subjects who are 20-65 aged, spontaneously consent this study and put their signature on the consent form, have diagnosis of metabolic syndrome, and are relevant below 2 of 3 matters 1) Homocysteine >= 11.5 umol/L 2) Fibrinogen >= 200 mg/dL 3) Hs-CRP > 1.0

Exclusion criteria

Exclusion criteria: 1)severe complications such as liver failure, heart failure, diseases related to blood. 2)pregnant 3)body weight <= 45 kg 4)shock events 5)bleeding tendency 6)Lipid abnormality caused by hypothyroidism, Cushing syndrome, obstructive bile duct disease, lupus, pancreatitis, malignant lymphoma or nephrosis 7)communcation disability 8)recent blood donation

Design outcomes

Primary

Measure	Time frame
risk factors of arterosclerosis	—

Secondary

Measure	Time frame
score of quality of life;peripheral blood flow index	—

Countries

Korea, Republic of

Contacts

Public ContactHye-won Park

Seoul National University Hospital

Outcome results